DPP4 Inhibitors Do Not Increase IBD Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-World Evidence in U.S. Adults
Diabetes Care 2019 Aug 30;[EPub Ahead of Print], T Wang, JY Yang, JB Buse, V Pate, H Tang, EL Barnes, RS Sandler, T StürmerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.